Abstract
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.
Antonio Fernández-Nebro, María V Irigoyen, Inmaculada Ureña, María A Belmonte-López, Virginia Coret, Francisco G Jiménez-Núñez, Gisela Díaz-Cordovés, María A López-Lasanta, Antonio Ponce, Manuel Rodríguez-Pérez, Enrique Calero and Pedro González-Santos
The Journal of Rheumatology December 2007, 34 (12) 2334-2342;
Antonio Fernández-Nebro
María V Irigoyen
Inmaculada Ureña
María A Belmonte-López
Virginia Coret
Francisco G Jiménez-Núñez
Gisela Díaz-Cordovés
María A López-Lasanta
Antonio Ponce
Manuel Rodríguez-Pérez
Enrique Calero
In this issue
The Journal of Rheumatology
Vol. 34, Issue 12
1 Dec 2007
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.
Antonio Fernández-Nebro, María V Irigoyen, Inmaculada Ureña, María A Belmonte-López, Virginia Coret, Francisco G Jiménez-Núñez, Gisela Díaz-Cordovés, María A López-Lasanta, Antonio Ponce, Manuel Rodríguez-Pérez, Enrique Calero, Pedro González-Santos
The Journal of Rheumatology Dec 2007, 34 (12) 2334-2342;
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.
Antonio Fernández-Nebro, María V Irigoyen, Inmaculada Ureña, María A Belmonte-López, Virginia Coret, Francisco G Jiménez-Núñez, Gisela Díaz-Cordovés, María A López-Lasanta, Antonio Ponce, Manuel Rodríguez-Pérez, Enrique Calero, Pedro González-Santos
The Journal of Rheumatology Dec 2007, 34 (12) 2334-2342;